NPS Pharmaceuticals, Inc. (NPSP) - Financial and Strategic SWOT Analysis Review

Date: May 15, 2014
Pages: 40
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NFAD2BFE5A7EN
Leaflet:

Download PDF Leaflet

NPS Pharmaceuticals, Inc. (NPSP) - Financial and Strategic SWOT Analysis Review
NPS Pharmaceuticals, Inc. (NPSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on the development of specialty therapeutics for the treatment of rare diseases and disorders. The company’s only marketed product is Gattex (teduglutide) indicated for the treatment of intestinal failure associated with short bowel syndrome.

NPS Pharmaceuticals, Inc. Key Recent Developments

Mar 25, 2014: NPS Pharmaceuticals Expands Executive Leadership Team to Support its U.S. and International Growth and Global Orphan-Drug Leadership
Feb 18, 2014: NPS Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Financial Outlook for 2014
Jan 08, 2014: NPS Pharmaceuticals Reports Preliminary 2013 Results and 2014 Financial Outlook
Jan 06, 2014: NPS Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Dec 06, 2013: NPS Pharmaceuticals to Present at Oppenheimer Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

NPS Pharmaceuticals, Inc. - Key Facts
NPS Pharmaceuticals, Inc. - Key Employees
NPS Pharmaceuticals, Inc. - Key Employee Biographies
NPS Pharmaceuticals, Inc. - Major Products and Services
NPS Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
NPS Pharmaceuticals, Inc., Pipeline Products by Therapy Area
NPS Pharmaceuticals, Inc., Pipeline Products by Development Phase
NPS Pharmaceuticals, Inc. - History
NPS Pharmaceuticals, Inc. - Company Statement
NPS Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

NPS Pharmaceuticals, Inc. - Business Description
NPS Pharmaceuticals, Inc. - Corporate Strategy
NPS Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
NPS Pharmaceuticals, Inc. - Strengths
Strength - Strong Intellectual Property Portfolio
Strength - Orphan Drug Designations – Gattex and Natpara
Strength - Sturdy Research and Development Activities
NPS Pharmaceuticals, Inc. - Weaknesses
Weakness - Dependence on Third Parties
NPS Pharmaceuticals, Inc. - Opportunities
Opportunity - Market Potential – SBS, Hyperparathyroidism
Opportunity - Strategic Agreements
Opportunity - US Osteoporosis Market
NPS Pharmaceuticals, Inc. - Threats
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Uncertain R&D Outcomes
Threat - Competitive Landscape
NPS Pharmaceuticals, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

NPS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
NPS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
NPS Pharmaceuticals, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

NPS Pharmaceuticals, Inc., Recent Developments
Mar 25, 2014: NPS Pharmaceuticals Expands Executive Leadership Team to Support its U.S. and International Growth and Global Orphan-Drug Leadership
Feb 18, 2014: NPS Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Financial Outlook for 2014
Jan 08, 2014: NPS Pharmaceuticals Reports Preliminary 2013 Results and 2014 Financial Outlook
Jan 06, 2014: NPS Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Dec 06, 2013: NPS Pharmaceuticals to Present at Oppenheimer Healthcare Conference
Dec 05, 2013: NPS Pharmaceuticals to Webcast Investor and Analyst Event
Nov 25, 2013: NPS Pharmaceuticals to Present at Deutsche Bank BioFEST Conference
Nov 20, 2013: NPS Pharmaceuticals named one of New Jersey’s 50 fastest growing companies by NJBIZ
Nov 18, 2013: NPS Pharmaceuticals’ president and CEO Dr. Francois Nader receives Ernst & Young National Entrepreneur Of The Year 2013 award in the life sciences category
Nov 11, 2013: NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

NPS Pharmaceuticals, Inc., Key Facts
NPS Pharmaceuticals, Inc., Key Employees
NPS Pharmaceuticals, Inc., Key Employee Biographies
NPS Pharmaceuticals, Inc., Major Products and Services
NPS Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
NPS Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
NPS Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
NPS Pharmaceuticals, Inc., History
NPS Pharmaceuticals, Inc., Subsidiaries
NPS Pharmaceuticals, Inc., Key Competitors
NPS Pharmaceuticals, Inc., Ratios based on current share price
NPS Pharmaceuticals, Inc., Annual Ratios
NPS Pharmaceuticals, Inc., Interim Ratios
NPS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
NPS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
NPS Pharmaceuticals, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

NPS Pharmaceuticals, Inc., Pipeline Products by Therapy Area
NPS Pharmaceuticals, Inc., Pipeline Products by Development Phase
NPS Pharmaceuticals, Inc., Performance Chart (2009 - 2013)
NPS Pharmaceuticals, Inc., Ratio Charts
NPS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
NPS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

NPS Pharmaceuticals, Inc. (NPSP) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: